BU-NOT-SET

CONTACT US
Overcoming the challenges surrounding manufacturing oncolytic viruses
  • Biologics
Virus
Insight
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
  • Drug product
  • Industry trends
DCAT insights
Insight
Developing a robust dissolution method for low-dose formulations
  • Analytical chemistry
  • Drug product
low-dose formulation
White paper
Sustainability report 2022
  • Sustainability
Sustainability report 2022
Report
Navigating the changing oral solid dose landscape
  • Drug product
  • Industry trends
Oral solid dose
Insight
The opportunities and obstacles of filling and packaging pre-filled syringes
  • Drug product
  • Manufacturing
pre-filled syringes
Insight
Tips for facilitating a successful tech transfer between sponsor and CDMO
  • Drug product
  • Industry trends
Tech transfer
Insight
Alternative drug delivery formulation & device expertise
  • Drug product
  • Industry trends
Industry trends
Insight
The 3 key trends shaping the CDMO industry in 2023 and beyond
  • Industry trends
CDMO trends
Insight
Insight
  • Industry trends
A CDMO’s insight into the pharma M&A landscape
Insight
  • Industry trends
Recipharm’s continuous global support throughout the COVID-19 pandemic
Insight
  • Manufacturing
Is outsourcing the most viable pathway for innovators?
Case study
  • Drug product
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
Insight
  • Industry trends
Recipharm Wins two 2020 CMO Leadership Awards
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list